CURRENT GRADUATE STUDENTS
Molecular and Medical Pharmacology Student and Postdoc Representatives
Each year graduate students and postdocs are elected by their peers to representative positions. Students and postdocs will be selected both from the Molecular and Medical Pharmacology graduate program and the Interdepartmental Program in Biomedical Physics. These representatives play a critical role in enriching graduate student life through recruitment and orientation of new students, participation in Graduate Training Committee meetings, organization of the Pharmacology retreats, coordinating special events and communicating the needs of the graduate students to the Graduate Training Committee and the department chair. They also participate in faculty meetings. Through these activities, the student representatives gain valuable leadership experience, the ability to positively influence the department’s graduate program, and serve as an information conduit between the graduate students and the faculty.
Meet our current representatives:
Tiancheng Fang is a 3rd year in John Chute's lab. Her research interest is the Hematopoietic Stem Cell Regeneration after injury. She received her BS in Bioscience from Nankai University in China in 2014. Besides research, Tiancheng enjoys Hiking and enjoy good food with friends.
Mr. Richard A. Morgan is currently pursuing a combined MD/PhD degree through the Medical Scientist Training Program and is a student in the DREW/UCLA Medical Education Program. He received his MSc in Biotechnology at Johns Hopkins University and has contributed to the publication of over 10 original scientific articles in the fields of pathology, oncology, and surgery. Mr. Morgan’s previous research focused on identifying the genetic factors underlying metastatic progression in pancreatic cancer. He is currently completing his graduate training in the laboratory of Dr. Donald B. Kohn where he is developing high-throughput methods for engineering gene therapy vectors. Mr. Morgan has received multiple fellowships and scholarships in support of his endeavors, including grants from Charles R. Drew University of Medicine and Science, and the National Medical Association, and fellowships from the National Heart, Lung, and Blood Institute, and is a recipient of the prestigious Franklin C. McLean award.
Allison Sharrow began her research career at the University of Pittsburgh, first using biochemistry to better understand Rb/E2F signaling in cancer. Her post-baccalaureate research departed from cancer to delineate the effects of death receptor signaling in osteoblast function and to better understand how post-menopausal hormone changes cause osteoporosis. Dr. Sharrow’s graduate thesis at The Johns Hopkins University School of Medicine drew her back to cancer. During this time, she identified and characterized ovarian cancer stem cells and discovered several novel therapeutic strategies to eliminate these chemoresistant cells. Since then, she has bridged cancer stem cells and tumor immunology to better understand the interactions between these crucial cell types.